Advanced Enzymes Technologies Ltd. reported a 2% increase in revenue to ₹1,719 million for Q3 FY26. EBITDA decreased by 11% to ₹494 million. However, PAT increased by 11% to ₹432 million. For the nine months ended December 31, 2025, revenue grew by 15% to ₹5,424 million, with PAT up by 20% to ₹1,284 million.
Financial Performance Q3 FY26
Advanced Enzymes Technologies Ltd. announced its consolidated financial results for the third quarter of fiscal year 2026, showcasing mixed performance across key metrics.
Key highlights from the report include:
- Revenue: Increased by 2% year-over-year to ₹1,719 million from ₹1,691 million in Q3 FY25.
- EBITDA: Decreased by 11% to ₹494 million, compared to ₹553 million in the same quarter last year.
- PAT: Increased by 11% to ₹432 million, up from ₹389 million in Q3 FY25.
Nine Months Performance (9M FY26)
The company also reported cumulative results for the nine-month period ended December 31, 2025:
- Revenue: Grew by 15% to ₹5,424 million, from ₹4,697 million in 9M FY25.
- EBITDA: Increased by 11% to ₹1,658 million from ₹1,488 million in the previous year.
- PAT: Increased by 20% to ₹1,284 million from ₹1,072 million.
Segmental Performance
A breakdown of revenue by segment shows varied performance:
- Human Nutrition: Contributed approximately 56% of total revenue, with sales of ₹962 million, a 6% decrease year-over-year. For 9M FY26 the segment grew by 12% to ₹3,396 million.
- Animal Nutrition: Represented 14% of revenue, with a 22% increase to ₹241 million. Nine-month revenue stood at ₹694 million, a 26% increase.
- Industrial Bio-processing: Contributed 21% with a 13% increase to ₹361 million. The segment grew by 15% on YTD basis to ₹852 million.
- Specialized Manufacturing: Accounted for 9% of revenue, remaining flat at ₹155 million. The segment outperformed by 25% on YTD basis to ₹482 million.
Geographical Performance
The company’s geographical performance for Q3 FY26 includes:
- India: 47% of revenue, a 6% increase.
- Americas: 29% of revenue, an 11% decrease.
- Europe: 6% of revenue, a 9% decrease.
- Asia: 13% of revenue, a 14% increase.
- Rest of the World: 6% of revenue, a 40% increase.
Source: BSE
